av/iol-chemicals-and-phar--big.svg

NSE:IOLCP

IOL Chemicals and Pharmaceuticals Limited

  • Stock

INR

Last Close

64.79

02/05 08:49

Market Cap

24.69B

Beta: 1.03

Volume Today

534.86K

Avg: 415.18K

PE Ratio

14.92

PFCF: -

Dividend Yield

0.91%

Payout:0%

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
Mar '25
average inventory
2.03B
-
2.21B
8.81%
2.45B
11.15%
2.35B
4.18%
1.98B
15.69%
1.88B
5.03%
2.41B
28.24%
3.53B
46.07%
3.68B
4.31%
3.75B
2.03%
3.93B
4.68%
average payables
918.11M
-
934.36M
1.77%
1.35B
44.72%
1.43B
5.91%
1.26B
11.71%
1.53B
21.15%
2.12B
38.70%
3.24B
52.53%
3.62B
11.63%
3.92B
8.28%
4.48B
14.47%
average receivables
938.05M
-
938.05M
0%
1.82B
-
4.40B
142.11%
5.12B
16.37%
4.88B
4.55%
4.92B
0.86%
book value per share
51.98
-
35.15
32.38%
33.69
4.14%
38.38
13.93%
84.39
119.85%
143.01
69.46%
216.08
51.10%
237.20
9.77%
256.81
8.27%
274.51
6.89%
57.44
79.07%
capex per share
-1.48
-
-5.06
241.61%
-3.99
21.22%
-8.60
115.71%
-10.77
25.16%
-14.11
31.05%
-18.55
31.46%
-26.11
40.75%
-36.08
38.17%
46.70
229.44%
7.27
84.44%
capex to depreciation
-0.20
-
-0.90
339.59%
-0.75
16.67%
-1.60
113.83%
-1.87
17.10%
-2.25
19.86%
-2.78
23.74%
-3.54
27.45%
-4.59
29.50%
4.36
194.97%
2.97
31.93%
capex to operating cash flow
0.13
-
-1.51
1,297.59%
-0.29
80.90%
-0.40
40.33%
-0.22
45.14%
-0.17
23.09%
-0.28
67.20%
-1.65
478.18%
-1.73
5.16%
0.95
154.56%
1.20
26.49%
capex to revenue
-0.02
-
-0.05
199.20%
-0.03
31.35%
-0.05
59.32%
-0.04
27.24%
-0.04
17.79%
-0.06
29.07%
-0.07
27.14%
-0.10
35.14%
0.13
234.55%
0.10
20.10%
cash per share
3.19
-
2.27
28.66%
2.93
28.58%
0.14
95.13%
2.40
1,583.64%
22.99
859.54%
57.71
150.97%
20.45
64.56%
7.97
61.05%
19.75
147.93%
2.77
85.96%
days of inventory on hand
278.98
-
201.16
27.90%
195.29
2.92%
106.42
45.51%
64.61
39.29%
63.10
2.33%
95.83
51.86%
93.70
2.22%
76.80
18.04%
108.96
41.88%
78.33
28.11%
days payables outstanding
91.83
-
102.92
12.08%
114.38
11.14%
68.02
40.53%
41.14
39.51%
62.62
52.20%
77.54
23.83%
93.56
20.66%
74.13
20.77%
120.34
62.33%
92.87
22.82%
days sales outstanding
71.17
-
68.10
-
86.86
27.54%
83.47
3.90%
80.65
3.39%
90.18
11.82%
debt to assets
0.57
-
0.58
3.08%
0.55
6.35%
0.51
6.13%
0.30
41.27%
0.05
83.22%
0.00
96.65%
0.02
1,220.93%
0.04
76.22%
0.01
63.02%
0.05
236.62%
debt to equity
1.92
-
2.45
27.58%
2.36
3.46%
1.96
17.25%
0.60
69.38%
0.07
87.79%
0.00
97.04%
0.03
1,357.22%
0.05
67.71%
0.02
61.60%
0.07
241.14%
dividend yield
0.02
-
0.01
64.45%
0.02
132.12%
0.01
16.57%
0.01
6.69%
0.01
5.07%
earnings yield
-0.58
-
-0.10
82.99%
0.01
112.01%
0.06
410.17%
0.21
245.15%
0.36
71.61%
0.14
61.68%
0.08
41.64%
0.08
3.76%
0.06
27.82%
0.05
10.78%
enterprise value
4.99B
-
8.44B
69.12%
7.85B
6.97%
8.76B
11.55%
13.96B
59.40%
10.32B
26.05%
31.84B
208.47%
21.17B
33.51%
17.39B
17.85%
22.48B
29.25%
19.12B
14.94%
enterprise value over ebitda
66.12
-
23.03
65.17%
9.12
60.39%
7.23
20.70%
3.36
53.53%
1.76
47.51%
5.21
195.17%
7.41
42.36%
6.92
6.65%
8.62
24.60%
8.51
1.33%
ev to operating cash flow
-10.62
-
47.66
548.69%
10.08
78.86%
7.31
27.42%
5.11
30.14%
2.19
57.12%
8.38
282.63%
22.75
171.39%
14.22
37.48%
7.75
45.52%
10.70
38.14%
ev to sales
1.30
-
1.45
12.10%
1.10
24.02%
0.91
17.60%
0.84
7.34%
0.55
34.32%
1.64
195.37%
0.98
40.32%
0.78
19.65%
1.05
34.36%
0.92
12.75%
free cash flow per share
-13.26
-
-1.70
87.16%
9.87
679.42%
12.70
28.65%
37.83
197.96%
68.70
81.60%
46.56
32.23%
-10.26
122.04%
-15.25
48.65%
2.71
117.77%
-1.19
143.87%
free cash flow yield
-0.46
-
-0.02
95.19%
0.16
803.22%
0.16
0.17%
0.19
20.36%
0.39
106.63%
0.08
78.36%
-0.03
134.33%
-0.05
85.88%
0.01
113.27%
-0.02
360.52%
graham net net
-94.07
-
-88.24
6.20%
-85.58
3.02%
-64.18
25.01%
-63.98
0.30%
-24.16
62.24%
69.75
388.68%
24.22
65.28%
12.84
46.98%
8.33
35.13%
-1.61
119.35%
graham number
139.83
-
77.52
44.56%
23.88
69.20%
65.24
173.23%
282.77
333.42%
452.06
59.87%
608.72
34.66%
390.42
35.86%
370.06
5.22%
376.08
1.63%
66.68
82.27%
income quality
0.70
-
-0.46
165.17%
14.22
3,197.05%
3.82
73.10%
0.81
78.75%
0.88
8.71%
0.66
24.77%
0.41
37.74%
0.65
56.62%
2.16
232.93%
1.29
40.00%
intangibles to total assets
0.00
-
0.00
200.03%
0.00
9.02%
0.00
6.35%
0.00
35.44%
0.00
44.78%
0.00
12.67%
0.00
377.51%
0.00
143.01%
0.01
27.80%
0.01
0.57%
interest coverage
-1.39
-
-0.85
39.16%
0.11
112.82%
1.54
1,315.96%
8.21
433.15%
34.31
317.89%
608.96
1,675.01%
99.70
83.63%
12.45
87.51%
30.70
146.48%
8.83
71.24%
interest debt per share
113.29
-
94.65
16.45%
88.57
6.43%
85.56
3.40%
58.82
31.25%
13.27
77.44%
0.63
95.26%
7.90
1,155.69%
16.40
107.58%
8.32
49.25%
4.49
46.10%
inventory turnover
1.31
-
1.81
38.69%
1.87
3.00%
3.43
83.51%
5.65
64.71%
5.78
2.39%
3.81
34.15%
3.90
2.27%
4.75
22.01%
3.35
29.52%
4.66
39.11%
invested capital
1.92
-
2.45
27.58%
2.36
3.46%
1.96
17.25%
0.60
69.38%
0.07
87.79%
0.00
97.04%
0.03
1,357.22%
0.05
67.71%
15.94B
30,108,493,978,098.22%
17.34B
8.80%
market cap
1.14B
-
4.02B
252.98%
3.54B
12.08%
4.54B
28.44%
11.25B
147.57%
10.01B
11.06%
32.13B
221.10%
20.76B
35.38%
16.61B
20.03%
22.23B
33.84%
18.73B
15.73%
net current asset value
-2.11B
-
-2.31B
9.28%
-2.16B
6.22%
-2.10B
2.95%
205.20M
109.78%
3.09B
1,405.46%
6.73B
117.74%
5.11B
24.03%
4.06B
20.55%
4.87B
19.93%
4.57B
6.15%
net debt to ebitda
51.01
-
12.04
76.39%
5.01
58.41%
3.48
30.55%
0.65
81.27%
0.05
91.76%
-0.05
190.23%
0.14
392.05%
0.31
120.63%
0.10
69.18%
0.17
79.85%
net income per share
-16.72
-
-7.60
54.55%
0.75
109.90%
4.93
555.23%
42.11
754.46%
63.51
50.82%
76.21
20.00%
28.56
62.52%
23.70
17.02%
22.90
3.38%
3.44
84.98%
operating cash flow per share
-11.78
-
3.36
128.52%
13.86
312.40%
21.30
53.71%
48.60
128.16%
82.81
70.40%
65.11
21.38%
15.85
75.66%
20.83
31.39%
49.41
137.26%
6.08
87.70%
payables turnover
3.97
-
3.55
10.78%
3.19
10.02%
5.37
68.15%
8.87
65.33%
5.83
34.30%
4.71
19.24%
3.90
17.12%
4.92
26.21%
3.03
38.40%
3.93
29.58%
receivables turnover
5.13
-
5.36
-
4.20
21.59%
4.37
4.05%
4.53
3.51%
4.05
10.57%
research and ddevelopement to revenue
return on tangible assets
-0.10
-
-0.05
45.65%
0.01
110.02%
0.03
552.42%
0.25
645.14%
0.31
22.25%
0.28
10.17%
0.09
69.01%
0.07
19.26%
0.06
12.85%
0.04
29.16%
revenue per share
96.51
-
110.19
14.17%
126.44
14.75%
171.18
35.39%
294.44
72.00%
327.58
11.25%
333.64
1.85%
369.36
10.71%
377.64
2.24%
363.30
3.80%
70.77
80.52%
roe
-0.32
-
-0.22
32.79%
0.02
110.33%
0.13
475.10%
0.50
288.65%
0.44
11.00%
0.35
20.58%
0.12
65.86%
0.09
23.36%
0.08
9.61%
0.06
28.21%
roic
-0.11
-
-0.06
43.10%
0.01
110.59%
0.13
1,799.43%
0.36
182.02%
0.42
19.39%
0.35
17.13%
0.13
64.28%
0.10
24.18%
0.22
133.44%
0.05
77.28%
sales general and administrative to revenue
0.00
-
0.00
6.62%
0.00
19.85%
0.00
15.96%
0.00
48.43%
0.00
58.94%
0.00
0.28%
0.00
26.71%
0.00
19.29%
shareholders equity per share
51.98
-
35.15
32.38%
33.69
4.14%
38.38
13.93%
84.39
119.85%
143.01
69.46%
216.08
51.10%
237.20
9.77%
256.81
8.27%
274.51
6.89%
57.44
79.07%
stock based compensation to revenue
tangible asset value
2.07B
-
1.84B
11.00%
1.88B
2.32%
2.15B
13.97%
4.74B
120.55%
8.13B
71.67%
12.60B
54.95%
13.89B
10.25%
14.99B
7.91%
15.99B
6.68%
16.74B
4.71%
tangible book value per share
51.98
-
35.15
32.38%
33.69
4.14%
38.21
13.40%
84.26
120.53%
142.92
69.62%
215.98
51.12%
236.59
9.54%
255.30
7.91%
272.36
6.68%
56.98
79.08%
working capital
749.47M
-
763.76M
1.91%
859.64M
12.55%
819.90M
4.62%
2.31B
181.95%
3.89B
68.12%
7.32B
88.28%
5.67B
22.46%
4.64B
18.20%
5.60B
20.61%
5.41B
3.28%

All numbers in INR (except ratios and percentages)